News

The following is a summary of “Screening for primary aldosteronism in 1,181 Swedish primary care patients with hypertension,” ...
A new blood pressure medication called lorundrostat has shown promising results in reducing blood pressure among patients ...
Perspectives from Keith Churchwell, MD, FAHA Keith C. Ferdinand, MD CHICAGO — The investigational aldosterone synthase inhibitor lorundrostat effectively lowered 24-hour BP for adults with well ...
Lorundrostat is in a new class of blood pressure medications called aldosterone synthase inhibitors (ASIs). Several ASIs are currently in development and are designed to work by disrupting the ...